Clinical trial NCT01054131: Peer to Peer Mentoring: Facilitating Individuals With Early Inflammatory Arthritis to Manage Their Arthritis: Peer Mentoring Program
Official title: Peer to Peer Mentoring: Facilitating Individuals With Early Inflammatory Arthritis to Manage Their Arthritis: Peer Mentoring Program
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Early Inflammatory Arthritis
Chronic Disease
Keywords: peer support
peer mentor
self-management
early inflammatory arthritis
chronic disease
Lead sponsor: Sunnybrook Health Sciences Centre
Sponsor class: OTHER
Collaborators: name: Canadian Arthritis Network
First posted: 2010-01-22
Enrollment: 10
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: SUPPORTIVE_CARE

Brief summary: Inflammatory arthritis (IA) is a major cause of long-term disability. Peer support may be a solution to the common problem of delayed treatment. Early peer support may result in improved use of therapy, higher self-efficacy, reduced anxiety, and improved coping in the first two years post-diagnosis. The whole intervention study comprises of two parts: The first part involves the development and testing of a peer mentor training initiative, which is called "Peer to Peer Mentoring: Facilitating Individuals with Early Inflammatory Arthritis to Manage their Arthritis - Peer Mentor Training". The second part, which is the focus of this study, involves the delivery of a one-on-one peer support intervention from a trained peer mentor to an individual newly diagnosed with EIA. The feasibility and acceptability of the program will be determined, as well as the health outcomes following the participation of the program.


Eligibility criteria: Inclusion Criteria:

1. Have EIA disease duration within 6-52 weeks
2. At least 3 swollen joints, assessed by the treating rheumatologist, OR positive compression test for the metacarpophalangeal joints OR positive compression test for the metatarsophalangeal joints OR at least 30 minutes of morning stiffness
3. Prescription of a DMARD/biologic by the treating rheumatologist
4. Ability to speak and understand English without the aid of a secondary support person; AND
5. Capability to provide informed consent.

Exclusion Criteria:

1. IA disease duration less than 6 weeks or greater than 1 year
2. Previous or ongoing DMARD or biologic treatment
3. Inability to speak or read grade 6 English; AND
4. Inability to provide informed consent

Primary outcomes:
measure: DMARD adherence
timeFrame: 0, 3, 6 months
Secondary outcomes:
measure: coping efficacy
timeFrame: 0, 3 6 months
measure: self-management
timeFrame: 0, 3, 6 months
measure: anxiety
timeFrame: 0, 3, 6 months
measure: self efficacy
timeFrame: 0, 3, 6 months
measure: social support
timeFrame: 0, 3, 6 months
Other outcomes:
Locations:
city: Toronto
country: Canada
facility: Sunnybrook Health Sciences Centre
state: Ontario
Study officials:
affiliation: Rheumatologist, Sunnybrook Health Sciences Centre
name: Mary J Bell, MD, FRCPC
role: PRINCIPAL_INVESTIGATOR
References:
citation: Sandhu S, Veinot P, Embuldeniya G, Brooks S, Sale J, Huang S, Zhao A, Richards D, Bell MJ. Peer-to-peer mentoring for individuals with early inflammatory arthritis: feasibility pilot. BMJ Open. 2013 Mar 1;3(3):e002267. doi: 10.1136/bmjopen-2012-002267.